Allscripts Healthcare Stock
Price
Target price
€8.20
€8.20
-5.750%
-0.5
-5.750%
€11.95
01.07.24 / Stuttgart Stock Exchange
WKN: 607917 / Symbol: MDRX / Name: Allscripts / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Allscripts Healthcare Stock
Allscripts Healthcare took a tumble today and lost -€0.500 (-5.750%).
The community is currently still undecided about Allscripts Healthcare with 2 Buy predictions and 0 Sell predictions.
With a target price of 11 € there is a positive potential of 34.15% for Allscripts Healthcare compared to the current price of 8.2 €.
Pros and Cons of Allscripts Healthcare in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allscripts Healthcare vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Allscripts Healthcare | -5.750% | -3.529% | 17.143% | -26.126% | -11.351% | -46.405% | -19.196% |
MicroVision Inc | 1.790% | 4.635% | -7.079% | -76.306% | -60.756% | -92.656% | 35.767% |
Fonar Corp. New | 1.380% | 5.000% | 3.521% | -4.545% | -16.949% | 1.379% | -22.542% |
Fluidigm Corp. | -3.090% | -0.633% | -29.279% | -9.770% | -23.786% | -67.424% | - |
Comments
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at TD Cowen from $26.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat